"The U.S. Food and Drug Administration today approved a new use for Jakafi (ruxolitinib) to treat patients with polycythemia vera, a chronic type of bone marrow disease. Jakafi is the first drug approved by the FDA for this condition.
Calcium Chloride Injection 10%
Calcium chloride (calcium chloride) is indicated in the immediate treatment of hypocalcemic tetany. Other therapy, such as parathyroid hormone or vitamin D, may be indicated according to the etiology of the tetany. It is also important to institute oral calcium therapy as soon as practicable. Calcium salts have been used as adjunctive therapy in a number of conditions, including the following:
Insect bites or stings, such as Black Widow Spider bites.
Sensitivity reactions, particularly when characterized by urticaria.
As an aid in the treatment of depression due to overdosage of magnesium sulfate.
As an aid in the management of the acute symptoms in lead colic.
DOSAGE AND ADMINISTRATION
The usual adult dose of this preparation varies from 5 to 10 mLat intervals of 1 to 3 days.
Parenteral drug products should be inspected visually for particulate matter and discoloration, whenever solution and container permit.
Calcium Chloride (calcium chloride) Injection, USP10%. (No preservative added).
NDC 0517-2710-2510 mLsingle dose vialpacked in a box of 25
Rev. 2/00. American Regent Laboratories Inc., Shirley, NY 11967. FDA revision date: 3/18/2003This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 9/30/2008
Additional Calcium Chloride Injection 10% Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.